We are pleased to announce that DayDrop Advanced® in its single-dose and multi-dose versions has achieved MDR certification as a medical device, reaffirming its safety and efficacy in ocular health care.
🔬 DayDrop Advanced® is an innovative ophthalmic solution, formulated with hyaluronic acid (HA) and gamma-poly-glutamic acid (γ-PGA). This technological combination provides relief from the symptoms of dry eye syndrome, offering immediate hydration and lubrication of the ocular surface.
💡 Key benefits:
- Immediate hydration for enhanced comfort.
- Advanced protection against corneal dryness.
- Stabilization of the tear film and increased bioadhesion.
- Reduction of symptoms like burning, itching, and eye fatigue.
- Compatible with contact lens use and preservative-free.
This certification not only guarantees the quality and safety of DayDrop Advanced®, but also reinforces our commitment to innovation in cutting-edge ophthalmic solutions.
We thank the entire i+Med team for their exceptional work and our customers our customers for continuing to trust us. We will continue to develop products that care for and improve people’s ocular health. ✨❤️